Miracle Mile Advisors, LLC Merck & Co., Inc. Transaction History

Miracle Mile Advisors, LLC

$6.11 Billion
Q3 2025

A detailed history of Miracle Mile Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 103,351 shares of MRK stock, worth $8.89 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

103,351

Previous 104,345 0.95%

Holding current value

$8.89 Million

Previous $8.26 Million 5.02%

% of portfolio

0.14%

Previous 0.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$77.6 - $87.37 $77,134 - $86,845	-994 Reduced 0.95%	103,351 $8.67 Million
Q2 2025 Jul 22, 2025	BUY	$73.47 - $87.12 $237,895 - $282,094	3,238 Added 3.2%	104,345 $8.26 Million
Q1 2025 Apr 14, 2025	BUY	$83.01 - $101.02 $726,088 - $883,621	8,747 Added 9.47%	101,107 $9.08 Million
Q4 2024 Jan 13, 2025	BUY	$96.31 - $114.76 $2.16 Million - $2.57 Million	22,382 Added 31.98%	92,360 $9.19 Million
Q3 2024 Oct 07, 2024	SELL	$111.15 - $128.97 $881,641 - $1.02 Million	-7,932 Reduced 10.18%	69,978 $7.95 Million
Q2 2024 Jul 18, 2024	BUY	$123.8 - $132.96 $135,561 - $145,591	1,095 Added 1.43%	77,910 $9.65 Million
Q1 2024 Apr 18, 2024	SELL	$113.24 - $131.95 $273,701 - $318,923	-2,417 Reduced 3.05%	76,815 $10.1 Million
Q4 2023 Jan 22, 2024	BUY	$100.18 - $109.02 $5.58 Million - $6.07 Million	55,697 Added 236.66%	79,232 $8.64 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $106,965 - $118,788	-1,039 Reduced 4.23%	23,535 $2.42 Million
Q2 2023 Jul 13, 2023	SELL	$108.61 - $118.38 $1.31 Million - $1.43 Million	-12,055 Reduced 32.91%	24,574 $2.84 Million
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $615,684 - $686,977	-5,981 Reduced 14.04%	36,629 $3.9 Million
Q4 2022 Jan 20, 2023	BUY	$87.44 - $112.11 $2.37 Million - $3.04 Million	27,126 Added 175.19%	42,610 $0
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $183,176 - $205,778	2,167 Added 16.27%	15,484 $1.33 Million
Q2 2022 Jul 15, 2022	SELL	$83.49 - $94.64 $24,796 - $28,108	-297 Reduced 2.18%	13,317 $1.21 Million
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $170,984 - $191,662	2,326 Added 20.61%	13,614 $1.12 Million
Q4 2021 Jan 18, 2022	BUY	$72.28 - $90.54 $35,634 - $44,636	493 Added 4.57%	11,288 $865,000
Q3 2021 Nov 01, 2021	BUY	$71.68 - $78.83 $266,864 - $293,484	3,723 Added 52.64%	10,795 $811,000
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $197,360 - $218,300	2,807 Added 65.81%	7,072 $550,000
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $293,687 - $345,934	4,265 New	4,265 $329,000
Q4 2020 Jan 19, 2021	SELL	$71.77 - $79.65 $179,783 - $199,523	-2,505 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $3.25 Million - $3.69 Million	-44,445 Reduced 94.66%	2,505 $208,000
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $2.41 Million - $2.74 Million	34,196 Added 268.12%	46,950 $3.63 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $653,241 - $905,424	10,310 Added 421.85%	12,754 $981,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $189,605 - $213,947	2,444 New	2,444 $222,000

Others Institutions Holding MRK

# of Institutions

3,859

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

29.9M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $218B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.

Account

Miracle Mile Advisors, LLC Merck & Co., Inc. Transaction History